Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Apr 2019 01:16 PM
RNS
Holding(s) in Company
18 Apr 2019 09:24 AM
RNS
Change of Registered Office
17 Apr 2019 03:26 PM
RNS
Holding(s) in Company
10 Apr 2019 07:00 AM
RNS
Statement of Indivior on Grand Jury Indictment
09 Apr 2019 07:00 AM
RNS
Holding(s) in Company
08 Apr 2019 07:00 AM
RNS
Indivior Presents RECOVER Study Data at ASAM 2019
05 Apr 2019 01:30 PM
RNS
Indivior Announces New Data at ASAM Conference
04 Apr 2019 07:00 AM
RNS
Notice of Results
03 Apr 2019 10:38 AM
RNS
Holding(s) in Company
18 Mar 2019 04:27 PM
RNS
Holding(s) in Company
15 Mar 2019 05:00 PM
RNS
Holding(s) in Company
14 Mar 2019 02:00 PM
RNS
Annual Financial Report
08 Mar 2019 02:30 PM
RNS
Directorate Change
07 Mar 2019 02:00 PM
RNS
Patient-centered Outcomes Published
06 Mar 2019 10:37 AM
RNS
Director/PDMR Shareholding
04 Mar 2019 04:54 PM
RNS
Holding(s) in Company
01 Mar 2019 07:00 AM
RNS
Total Voting Rights
28 Feb 2019 03:31 PM
RNS
Holding(s) in Company
27 Feb 2019 01:00 PM
RNS
Indivior Launches PERSERIS (risperidone)
26 Feb 2019 03:10 PM
RNS
Director Declaration
20 Feb 2019 09:06 AM
RNS
Holding(s) in Company
20 Feb 2019 07:00 AM
RNS
Indivior Launches SUBOXONE Film Authorized Generic
19 Feb 2019 07:00 AM
RNS
The Lancet Publishes Phase 3 Results of SUBLOCADET
14 Feb 2019 07:00 AM
RNS
Final Results
12 Feb 2019 07:00 AM
RNS
Federal Court Denies Motion to Stay
05 Feb 2019 07:00 AM
RNS
Indivior Responds to CAFC Rehearing Decision
04 Feb 2019 07:05 AM
RNS
Indivior Enters into Agreement with Alvogen
04 Feb 2019 07:00 AM
RNS
Indivior to Divest Interest in China
01 Feb 2019 03:00 PM
RNS
Total Voting Rights
25 Jan 2019 07:00 AM
RNS
Indivior Granted Temporary Restraining Order
24 Jan 2019 09:28 AM
RNS
Holding(s) in Company
22 Jan 2019 03:51 PM
RNS
Holding(s) in Company
21 Jan 2019 07:00 AM
RNS
Notice of Results
09 Jan 2019 03:07 PM
RNS
Holding(s) in Company
03 Jan 2019 08:44 AM
RNS
Holding(s) in Company
20 Dec 2018 07:00 AM
RNS
Indivior publishes real-world RECOVER study design
18 Dec 2018 12:00 PM
RNS
Indivior Trading Update
13 Dec 2018 02:41 PM
RNS
Holding(s) in Company
12 Dec 2018 07:00 AM
RNS
Federal Court Declines Immediate Issue of Mandate
30 Nov 2018 02:45 PM
RNS
Indivior Prepays Debt
29 Nov 2018 07:00 AM
RNS
Holding(s) in Company
28 Nov 2018 02:39 PM
RNS
Holding(s) in Company
27 Nov 2018 07:00 AM
RNS
Indivior Announces Update Call
23 Nov 2018 07:00 AM
RNS
Health Canada Approves SUBLOCADE(TM)
21 Nov 2018 04:20 PM
RNS
Holding(s) in Company
21 Nov 2018 11:57 AM
RNS
Holding(s) in Company
21 Nov 2018 07:00 AM
RNS
Indivior Responds to Federal Court Decision
20 Nov 2018 04:40 PM
RNS
Second Price Monitoring Extn
20 Nov 2018 04:35 PM
RNS
Price Monitoring Extension
20 Nov 2018 03:28 PM
RNS
INDIVIOR MAKES STATEMENT ON COURT DECISION

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100